Position in TCRX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$4,337
-$652 QoQ
Shares Held
4,295
-13.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TCRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FEDERATED HERMES, INC. holds $2,365,237,857 across 147 Biotechnology names. TCRX ranks #128 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
687,816 | $227,577,679 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
254,946 | $196,981,475 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,286,303 | $111,869,771 | |
| 4 | MRNA |
Moderna, Inc.
|
1,977,079 | $100,435,613 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
2,987,107 | $99,530,405 | |
| 6 | INSM |
INSMED Inc
|
538,257 | $88,015,784 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
2,049,439 | $81,403,717 | |
| 8 | EYPT |
EyePoint, Inc.
|
5,669,589 | $73,081,000 |
All Filings in TCRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,337 | 4,295 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $4,989 | 4,989 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $3,969 | 2,181 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $3,162 | 2,181 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,011 | 2,182 | Shares | Defined | 2025-05-08 | |
| 2024-03-31 | $444 | 56 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||